Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anfernee Kai-Wing Tse
Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling
Oncotarget
Oncology
Related publications
A Novel Anti-Melanoma SRC-family Kinase Inhibitor
Oncotarget
Oncology
Figure 1: IGF-1R and EGFR Signaling Pathway.
IGF-1R as an Anti-Cancer Target--Trials and Tribulations
Chinese Journal of Cancer
Pharmacophore Modeling for Identification of Anti-Igf-1r Drugs and In-Vitro Validation of Fulvestrant as a Potential Inhibitor
PLoS ONE
Multidisciplinary
Efficacy of and Resistance to Anti-Igf-1r Therapies in Ewing's Sarcoma Is Dependent on Insulin Receptor Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
Evaluation of a Novel Hexavalent Humanized Anti-Igf-1r Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines
PLoS ONE
Multidisciplinary
Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor
Oncoscience
Cancer Research
Oncology
Meteorin-Like Facilitates Skeletal Muscle Repair Through a Stat3/Igf-1 Mechanism
Nature Metabolism
Internal Medicine
Cell Biology
Endocrinology
Physiology
Metabolism
Diabetes
Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway
Cancer Management and Research
Oncology
